Plasma tau and glial fibrillary acidic protein (GFAP) are promising biomarkers for identifying
traumatic brain injury (TBI) patients with intracranial trauma on computed tomography (CT) …

Background Serum glial fibrillary acidic protein (GFAP) and ubiquitin carboxyl-terminal
esterase L1 (UCH-L1) have recently received US Food and Drug Administration approval for …

Objectives To determine whether a panel of blood-based biomarkers can discriminate
between patients with suspected mild traumatic brain injury (mTBI) with and without …

Objective: Identification and validation of blood-based biomarkers for the diagnosis and
prognosis of mild traumatic brain injury (mTBI) is of critical importance. There have been …

The objective of this work was to analyze the relationships between traumatic brain injury
(TBI) on computed tomographic (CT) imaging and blood concentration of glial fibrillary acidic …

Blood-based biomarkers have been increasingly studied for diagnostic and prognostic
purposes in patients with mild traumatic brain injury (MTBI). Biomarker levels in blood have …

The aim of the study was to examine the ability of eight protein biomarkers and their
combinations in discriminating computed tomography (CT)-negative and CT-positive …

Importance Annually in the United States, at least 3.5 million people seek medical attention
for traumatic brain injury (TBI). The development of therapies for TBI is limited by the …

Importance Glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase L1 (UCH-
L1) have been widely studied and show promise for clinical usefulness in suspected …

Objective Traumatic brain injuries (TBIs) are largely underdiagnosed and may have
persistent refractory consequences. Current assessments for acute TBI are limited to …